Organoids & 3D modelsconfirmed
InSphero
3D microtissue models, assay services and the AkuraFlow microphysiological system for safety and efficacy testing.
Notable
Buying for scale: DOPPL (Lausanne organoids, late 2025) and PhenoVista Biosciences (San Diego imaging, May 2026).
Related deals
No tracked deals yet.
Related updates
No related news yet.